Author’s replyBMJ 2010; 341 doi: http://dx.doi.org/10.1136/bmj.c5837 (Published 19 October 2010) Cite this as: BMJ 2010;341:c5837
- Rodney A Hayward, professor of medicine and public health1
- 1Schools of Public Health and Medicine, Department of Internal Medicine, University of Michigan, Ann Arbor, Michigan, USA
The estimated relative risk reduction (RRR) for total mortality of 9% for primary prevention is quite similar to the 11-12% found for secondary prevention.1 2 3 It is just as accurate to summarise the literature as finding no evidence that statins’ RRR for primary prevention differs much from that for secondary prevention but that their absolute risk reduction …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial